CEACAM5 and neoplasm: There were no significant differences between the POI group and the no POI group in age, sex, body mass index (BMI), comorbidities, preoperative carcinoembryonic antigen (CEA), metastasis diameter and number, tumor differentiation, tumor location, primary tumor T stage or positive lymph node metastases.